Posted by Admin 1 year ago
On the 1 February this year the ACT Government approved the establishment of Epi Axis Therapeutics. Epi Axis was established to commercialise the innovative therapy developed by University of Canberra Professor in Molecular and Cellular Biology Dr Sudha Rao that aims to prevent breast cancer metastasis. Dr Rao and her team were the first to…
There is currently no therapy to fight recurrent, metastatic breast cancer, which is the major source of death in women with breast cancer. Furthermore, current first-line treatments have extensive side-effects.We are determined to fix that.
